医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

BioJapan 2013 World Business Forum Exhibitor Profiles

2013年09月25日 PM06:10
このエントリーをはてなブックマークに追加


 

YOKOHAMA, Japan

BioJapan 2013 World Business Forum takes place October 9 – 11 at the PACIFICO YOKOHAMA in Yokohama, Japan.

Business Wire is the official media partner for the BioJapan 2013. Breaking news releases, online press kits are available at Tradeshownews.com, Business Wire’s trade show, conference, and event news resource.

Listed below are the BioJapan 2013 exhibitor profiles.

 
Company:   Amino Up Chemical, Co., Ltd.
Booth:
Web:

http://aminoup.co.jp/e/

Seminar: Functional Food Summit: What is a Next Step Board in Functional Food Market
Date: Oct. 11 (Fri.), 2013 10:00-11:30 Annex Hall F202
Title: History and Future of the Health Food Development in Hokkaido
Description: To improve production of natural products and those added values in Hokkaido, the Hokkaido Food Complex International Strategy General Zone was designated in December, 2011. This year, the new claim system, “Hokkaido Health Claiming System”, was implemented on August 27th. In this system, Hokkaido Prefectural Office approves food products made in Hokkaido, which is made from a functional material with scientific evidences, and allows those product to be claimed that those have satisfactory evidences.
 
 
Company: DAINIPPON SCREEN MFG. CO., LTD.
Booth: C303
Ticker Symbol & Exchange: Tokyo:7735
Web:

http://www.screen.co.jp/eng/index.html

Dainippon Screen Mfg. Co., Ltd. has launched the Cell3iMager (3D cell imager). A bright field spheroid counter, allowing reagent-free follow-up and morphological observation, ideal for label-free assays of 3-D cell culture. It takes 1 minute for scanning one well plate and up to 4 plates can be set and scan at one time.
Cell3iMager can be scanned and measured cultivated well plate directly without any pre-processing and any reagent.

 
 
Company: Center for Joint Research, Hirosaki University
Booth: A613
Web:

http://www.cjr.hirosaki-u.ac.jp/

The Center for Joint Research is a think-tank which keeps close touch with local communities. The Center aims at promoting science and technology, developing industries and advancing the lives of people in the local area. The Center is achieving its goals by sharing the academic assets, including patented technology, and information accumulated at Hirosaki University with industries, etc. and by conducting joint research activities. Approximately 700 researchers in various fields of science/technology cooperate with problem solution.
By this exhibition, we introduce proteoglycan extracted from salmon nasal cartilages and the products including it. The proteoglycan attracts attention recently, because it is useful for health and the beauty.
 
 
Company: JSR Life Sciences Corporation
Booth: D306
Web:

http://www.jsrlifesciences.com

JSR Life Sciences Corporation (JLS) has set out for a unique life science company which continuously provides outstanding materials and applications for customers in life science and medical industries. Our products are based on the prominent material technologies cultivated for long time in JSR and incorporated with state-of-the-art technologies acquired through our global network. JLS will introduce the technologies and products for synthetic blocking reagent, exosome capture kit, 3D cell culture plate and Protein A affinity media in Bio Japan 2013.

 
 
Company: Kihara Memorial Yokohama Foundation
Booth: B202
Web:

http://www.kihara.or.jp

Kihara Memorial Yokohama Foundation is the hub of Yokohama-Kanagawa Bio-business network (www.yk-bio.net).
Yokohama Biopharmaceutical Research and Development Center (YBIRD) is the facilities run by the Foundation for research and development of protein drugs and of relating manufacturing technologies.
YBIRD consists of GMP pilot plant facilities and process development labs that provide services for pilot-scale preparation of protein APIs for pre-clinical and clinical studies. Process development and scale-ups services are also available. YBIRD welcomes collaborative R&D relating to protein drugs and relating manufacturing technologies.

 
 
Company: M Bio Technology Inc.
Booth: A204
Web:

http://www.mbiotech.org

M Bio Technology Inc. is the research-and-development type venture business established on January 5, 2005. Mycoplasma infection may cause not only pneumonia but asthma, arthritis, a nephritis, meningitis, encephalitis, angeitis, dermatitis, etc., and presents variegated condition, such as a rheumatic disease and a nervous system disorder. We put the world’s first result of research of the mycoplasma lipid antigen in practical use, and have challenged establishment and conquest of mycoplasma infection of an innovative diagnostic-prevention-cure. We are performing precise and quantitative diagnosis and development of a vaccine or an antibody drug, and wish joint development, a business tie-up, and investment.

 
 
Company: Ministry of Industry and Trade of the Russian Federation
Booth: А402
Web:

http://pharmmedexpo.ru/en/

The importance of biotechnology for Russian economy can hardly be underestimated. This is why Russian Ministry of Industry and Trade supports the countries’ participation in BioJapan2013.
We are sure that BioJapan2013 will help Russian delegates to establish new contacts and develop new business opportunities encouraging long term cooperation with partners from Japan and abroad.
We wish all participants successful work during the Forum and invite everyone to visit the Russian pavilion (Booth A402), and take part in a panel discussion dedicated to perspectives of Russian biotech industry and market that will be held at our booth on October 9-th.
 
 
Company: Otsuma Women’s University, Functional Materials Laboratory / Golden Orchid Brothers, Inc.
Booth: C704
Web:

http://www.koyamayoshiyuki.com/

We developed novel bio-adhesive hydrogels. All the ingredients are safe and approved as pharmaceutical additives. They form soft hydrogels absorbing blood or body fluid, and firmly adheres to the tissues. The gels are fully degradable in body.
This technique would provide a possibilities to develop new hemostatic devices, bio-adhesion barriers, or protective materials.
Clinical studies of these materials have already been carried out. Please find the clinical results in our web page.
We also developed a non-viral gene therapy systems. Animal clinical study is currently undertaken (also presented in the web).
 
 

About BioJapan

Since the inaugural meeting in 1986, BioJapan - Asia’s Premier Partnering Event for the Global Biotechnology Industry – has played an important role in facilitating interaction between Japanese and global companies / organizations and stimulating new business opportunities. This year’s 15th anniversary event will be attended by over 700 companies from 25 countries, who will actively participate in the matching system, and will feature exhibitions and seminars under the four major themes of “Life”, “Green”, “Functional Foods and Neutraceuticals” and “Biotechnolgoy Clusters and Ventures”.

Don’t miss out on this great opportunity to expand your business chances.
Register Now! > http://www.ics-expo.jp/biojapan/

About Business Wire

Business Wire, a Berkshire Hathaway company, is the global leader in press release distribution and regulatory disclosure. Investor relations, public relations, public policy and marketing professionals rely on Business Wire to accurately distribute market-moving news and multimedia, host online newsrooms and IR websites, build content marketing platforms and provide audience analysis that improves engagement with specified target markets. Founded in 1961, Business Wire is a trusted source for news organizations, journalists, investment professionals and regulatory authorities, delivering news directly into editorial systems and leading online news sources, while boosting SEO and social media engagement via its multi-patented simultaneous NX Network. Business Wire has more than 30 bureaus worldwide to securely meet the varying needs of communications professionals and news consumers.

Learn more at BusinessWire.com and the BusinessWired blog; follow updates on Twitter: @businesswire or on Facebook.

Click here to subscribe to Mobile Alerts for Business Wire

CONTACT

Business Wire
Global Event Services Group
US. +1-310-820-9473
http://www.businesswire.com
http://www.tradeshownews.com
twitter: @tradeshownews

同じカテゴリーの記事 

  • Hyperfine, Inc. Takes the Stage at ISMRM with Seventeen Abstracts Assessing the Potential of Using Swoop® System Images Across Multiple Care Settings and Clinical Conditions
  • ReNAgade Therapeutics宣布在ASGCT第27届年会上发表演讲
  • ReNAgade TherapeuticsがASGCT第27回年次総会でのプレゼンテーションの内容を発表
  • BeiGene Receives European Commission Approval for Tislelizumab as Treatment for Non-Small Cell Lung Cancer
  • The 2024 Japan Prize Award Ceremony Is Held with Their Majesties the Emperor and Empress of Japan in Attendance